Amgen Serves Up Solid Q2 on Sales, Takeda Payment
Amgen Inc.'s second-quarter figures blasted past expectations, as the Thousand Oaks, Calif.-based firm reported after market close Thursday total revenues of $4.5 billion, with adjusted earnings per share of $1.83, compared to consensus estimates of $4.1 billion and $1.54 per share.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST